MT

Michael Torgov

AB AbbVie: 9 patents #6 of 305Top 2%
LA Latency: 1 patents #7 of 24Top 30%
ML Medimmune Limited: 1 patents #31 of 168Top 20%
SG Seattle Genetics: 1 patents #6 of 24Top 25%
Overall (2018): #6,419 of 503,207Top 2%
10
Patents 2018

Issued Patents 2018

Patent #TitleCo-InventorsDate
10137204 Anti-DLL3 antibody drug conjugates for treating cancer Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu +1 more 2018-11-27
9968687 Anti-DLL3 antibody drug conjugates Philip Wilson Howard 2018-05-15
9962454 Antibody drug conjugates (ADC) that bind to 191P4D12 proteins Daulet Kadyl Satpayev, Robert Kendall Morrison, Karen Jane Meyrick Morrison, Jean Gudas, Aya Jakobovits +1 more 2018-05-08
9937268 Anti-DLL3 antibody drug conjugates and methods of use Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu +1 more 2018-04-10
9931421 Methods of delivering DLL3 antibody drug conjugates Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu +1 more 2018-04-03
9931420 Methods of making DLL3 antibody drug conjugates Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu +1 more 2018-04-03
9878053 Methods of delivering DLL3 antibody drug conjugates Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu +1 more 2018-01-30
9867887 Anti-DLL3 antibody drug conjugates Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu +1 more 2018-01-16
9861708 Kits containing DLL3 antibody drug conjugates Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu +1 more 2018-01-09
9855343 Anti-DLL3 antibody drug conjugates Robert A. Stull, Laura Saunders, Scott J. Dylla, Orit Foord, David Liu +1 more 2018-01-02